144 related articles for article (PubMed ID: 14616170)
21. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia.
Distrutti E; Fiorucci S; Hauer SK; Pensi MO; Vanasia M; Morelli A
Aliment Pharmacol Ther; 2002 Mar; 16(3):613-22. PubMed ID: 11876717
[TBL] [Abstract][Full Text] [Related]
22. Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion.
Rotondo A; Janssen P; Mulè F; Tack J
Int J Obes (Lond); 2013 May; 37(5):693-8. PubMed ID: 22846777
[TBL] [Abstract][Full Text] [Related]
23. Effects of age on proximal gastric motor and sensory function.
Rayner CK; MacIntosh CG; Chapman IM; Morley JE; Horowitz M
Scand J Gastroenterol; 2000 Oct; 35(10):1041-7. PubMed ID: 11099056
[TBL] [Abstract][Full Text] [Related]
24. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans.
Tack J; Broekaert D; Coulie B; Fischler B; Janssens J
Aliment Pharmacol Ther; 2003 Feb; 17(4):603-8. PubMed ID: 12622770
[TBL] [Abstract][Full Text] [Related]
25. Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.
Coffin B; Farmachidi JP; Rueegg P; Bastie A; Bouhassira D
Aliment Pharmacol Ther; 2003 Feb; 17(4):577-85. PubMed ID: 12622767
[TBL] [Abstract][Full Text] [Related]
26. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
Kahrilas PJ; Quigley EM; Castell DO; Spechler SJ
Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
[TBL] [Abstract][Full Text] [Related]
27. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
[TBL] [Abstract][Full Text] [Related]
28. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
[TBL] [Abstract][Full Text] [Related]
29. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
[TBL] [Abstract][Full Text] [Related]
30. Effects of tropisetron, a 5-HT3 receptor antagonist, on proximal gastric motor and sensory function in nonulcer dyspepsia.
Klatt S; Böck W; Rentschler J; Beckh K; Adler G
Digestion; 1999; 60(2):147-52. PubMed ID: 10095156
[TBL] [Abstract][Full Text] [Related]
31. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of a slow nutrient drinking test for evaluating gastric perception and accommodation.
Iida A; Konagaya T; Kaneko H; Funaki Y; Kanazawa T; Tokudome K; Hijikata Y; Masui R; Ogasawara N; Sasaki M; Yoneda M; Kasugai K
Digestion; 2011; 84(4):253-60. PubMed ID: 21952611
[TBL] [Abstract][Full Text] [Related]
33. Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers.
Kuiken SD; Lei A; Tytgat GN; Holman R; Boeckxstaens GE
Aliment Pharmacol Ther; 2002 Nov; 16(11):1955-62. PubMed ID: 12390105
[TBL] [Abstract][Full Text] [Related]
34. Alosetron does not affect the visceral perception of gastric distension in healthy subjects.
Zerbib F; Bruley des Varannes S; Oriola RC; McDonald J; Isal JP; Galmiche JP
Aliment Pharmacol Ther; 1994 Aug; 8(4):403-7. PubMed ID: 7986965
[TBL] [Abstract][Full Text] [Related]
35. Effect of intranasal sumatriptan on gastric tone and sensitivity to distension.
Sarnelli G; Janssens J; Tack J
Dig Dis Sci; 2001 Aug; 46(8):1591-5. PubMed ID: 11508654
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
[TBL] [Abstract][Full Text] [Related]
37. Effects of capsaicin on the sensorimotor function of the proximal stomach in humans.
Lee KJ; Vos R; Tack J
Aliment Pharmacol Ther; 2004 Feb; 19(4):415-25. PubMed ID: 14871281
[TBL] [Abstract][Full Text] [Related]
38. [Use of an electronic barostat for measurement of motor response of the proximal stomach to feeding and different nervous stimuli in man].
Parys V; Bruley des Varannes S; Ropert A; Rozé C; Galmiche JP
Gastroenterol Clin Biol; 1993; 17(5):321-8. PubMed ID: 8349065
[TBL] [Abstract][Full Text] [Related]
39. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans.
Coffin B; Bouhassira D; Chollet R; Fraitag B; De Meynard C; Geneve J; Lemann M; Willer JC; Jian R
Aliment Pharmacol Ther; 1996 Dec; 10(6):919-25. PubMed ID: 8971289
[TBL] [Abstract][Full Text] [Related]
40. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
Bouras EP; Talley NJ; Camilleri M; Burton DD; Heckman MG; Crook JE; Richelson E
Am J Gastroenterol; 2008 Aug; 103(8):2043-50. PubMed ID: 18803000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
